Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Change in Account Payables (2017 - 2025)

Purple Biotech has reported Change in Account Payables over the past 6 years, most recently at $173000.0 for Q1 2022.

  • Quarterly Change in Account Payables rose 1.17% to $173000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $101000.0 through Mar 2022, down 76.62% year-over-year, with the annual reading at $450000.0 for FY2025, 121.68% up from the prior year.
  • Change in Account Payables was $173000.0 for Q1 2022 at Purple Biotech, up from -$275000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $361000.0 in Q4 2019 and troughed at -$275000.0 in Q4 2021.
  • The 5-year median for Change in Account Payables is $101500.0 (2020), against an average of $55000.0.
  • Year-over-year, Change in Account Payables skyrocketed 373.48% in 2019 and then crashed 959.38% in 2021.
  • A 5-year view of Change in Account Payables shows it stood at -$132000.0 in 2018, then skyrocketed by 373.48% to $361000.0 in 2019, then plummeted by 91.14% to $32000.0 in 2020, then crashed by 959.38% to -$275000.0 in 2021, then soared by 162.91% to $173000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Change in Account Payables are $173000.0 (Q1 2022), -$275000.0 (Q4 2021), and $171000.0 (Q1 2021).